← Evidence map

ArticleCurrent oncology (Toronto, Ont.)2017

Trastuzumab in metastatic breast cancer after complete remission: an expensive commitment for an entire life?

D Bernardi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 28270736